benevolent.ai
BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence.
Verdict
A quick read before you dig into the full page.
- Best if
- BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence
- Pick this when
- BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence
Overview
BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.
Access & connections
Where you can use benevolent.ai.
Platforms
Capabilities
What this tool accepts, produces, and is strongest at.
Highlights
- AI-driven drug discovery platform
- Knowledge graph and proprietary ontologies
- Life science intelligence